Signal2026-07-26
PubMed

Sex-Specific Differences in Disease-Free, Progression-Free and Overall Survival Following Enfortumab Vedotin Therapy for Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.

Part of

Ferroptosis Targeted Lung Cancer Therapies